In a recent report by Kracht et al., CD8+ T cells specific for an insulin DRiP peptide were isolated from peripheral blood of patients with T1D and were demonstrated to specifically destroy human islet cells in vitro [173••]. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.